| AKT1 | AKT serine/threonine kinase 1 |
| CCNE2 | Cyclin E2 |
| CDCA5 | Cell division cycle-associated 5 |
| DEGs | Differentially expressed genes |
| DPEP1 | Dipeptidase 1 |
| E2 | 17β-estradiol |
| ER | Estrogen receptor |
| EPT | Estrogen plus progestogens treatment |
| ET | Estrogen treatment |
| FAM102A | Family with sequence similarity 102 member A |
| FDR | False discovery rate |
| GEO | Gene Expression Omnibus |
| HPA | The Human Protein Atlas database |
| HR | Hazards ratio |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| KNTC1 | Kinetochore-associated 1 |
| KRAS | KRAS proto-oncogene, GTPase |
| MCM10 | Minichromosome maintenance 10 replication initiation factor |
| MHT | Menopausal hormone therapy |
| MPA | Medroxyprogesterone acetate |
| MPA group | E2 + MPA vs. E2 |
| NEIL3 | Nei-like DNA glycosylase 3 |
| NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 |
| P4 | Progesterone |
| P4 group | E2 + P4 vs. E2 |
| PPI | Protein–protein interaction |
| PR | Progesterone receptor |
| PTEN | Phosphatase and tensin homolog |
| RAD51 | RAD51 recombinase |
| RPL22 | Ribosomal protein L22 |
| RR | Relative risk |
| TCF19 | Transcription factor 19 |
| TCGA | The Cancer Genome Atlas |
| TCGA-BRCA | The Cancer Genome Atlas Breast Invasive Carcinoma database |
| TP53 | Tumor protein p53 |
| WHI | Women’s Health Initiative |